GlassScriptPhysician profile
Paul S Lin
NPI 1801031885
$7,541.39
in general payments reported to CMS, 2019-2025
18 companies · $706 in 2025
The $706 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,143 · 2020: $292 · 2021: $655 · 2022: $1,181 · 2023: $1,880 · 2024: $685 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341 · Travel and Lodging: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.20 |
| Travel and Lodging | $930.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,794.46 | 2019 | |
| Boston Scientific Corporation | $1,337.96 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, Patient Trial Kit |
| Intuitive Surgical, INC. | $930.00 | 2023 | Da Vinci Surgical System |
| Abbott Laboratories | $828.72 | 2019-2023 | Proclaim |
| Medtronic, INC. | $694.34 | 2021-2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $526.33 | 2019-2023 | Intracept |
| Vertos Medical, INC. | $301.02 | 2022-2023 | Mild Device Kit |
| Biotronik Nro, INC. | $217.78 | 2024 | Prospera |
| Nevro Corp. | $207.19 | 2019-2021 | |
| Mml US, INC. | $187.03 | 2022 | |
| Spr Therapeutics, INC | $141.43 | 2023 | Sprint Pns System |
| Medtronic USA, INC. | $125.77 | 2020 | |
| Trice Medical, INC. | $125.55 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $49.32 | 2019-2021 | |
| Ibsa Pharma INC. | $23.92 | 2024 | Licart, Tirosint |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $20.08 | 2020 | |
| Bioventus LLC | $16.98 | 2023 | Durolane |
| Merck Sharp & Dohme LLC | $13.51 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.